- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05726409
Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes
Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes: A Pilot Study
Boston Medical Center (BMC) serves many underserved, low-income patients and has developed an innovative strategy to combat food insecurity including a preventative food pantry, a teaching kitchen, and a rooftop farm that provides fresh produce directly to the patients. The presence of this well-established, three-pronged approach places BMC in an ideal position to develop a nutritional education intervention that supports experiential learning in this high-risk population.
For this first exploratory study, 75 enrolled participants will be given a free mobile application with recipes designed to build habits. Participants will cook at least three meals weekly for two months using the app. Self-reported survey data and activity on the app will be collected and used to assess the feasibility of teaching cooking skills through a mobile application.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lauren Ciszak, MD
- Phone Number: 617-425-2000
- Email: ciszakl@ebnhc.org
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
Contact:
- Lauren Ciszak, MD
- Phone Number: 617-425-2000
- Email: ciszakl@ebnhc.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Access to an oven OR microwave, stovetop OR hot plate, and food storage.
- Access to the internet on a smartphone
- Owns a smartphone with iOS Apple Store or Google Play
- Reading proficiency in English
- Has a diagnosis of diabetes or prediabetes(Hb A1C> 5.6)
Exclusion Criteria:
- Inability to provide informed consent
- Taking any medications or has a condition that limits the ability to increase intake of fruits and vegetables (including warfarin and end-stage renal disease)
- Attended a Diabetes Self-Management Education (DSME) at BMC within the past year or plans to attend during the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mobile application user
Each participant will be sent an email with a link to download a mobile application to access the meal planner function.
|
Participants will use the meal planner function on the mobile application to plan and cook at least 3 meals a week for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Frequency of mobile app use
Time Frame: 12 weeks
|
Data will be collected by the mobile app on the frequency of use throughout the 12 week intervention.
|
12 weeks
|
Recipe completion rate
Time Frame: 12 weeks
|
Data will be collected by the mobile app on the rate of recipe completion throughout the 12 week intervention.
Higher rates of completion are considered more favorable.
|
12 weeks
|
Satisfaction with the mobile application
Time Frame: 12 weeks
|
An investigator developed satisfaction questionnaire will be used to assess satisfaction with the mobile application.
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in dietary patterns
Time Frame: baseline, 12 weeks
|
This outcome will be measured using PrimeScreen, which is a validated brief dietary screening tool developed by the Harvard School of Public Health.
It will provide the change in frequency of consumption of fruits, vegetables, lean protein, carbohydrates, fat, and processed foods.
|
baseline, 12 weeks
|
Change in nutrition knowledge
Time Frame: baseline, 12 weeks
|
Change in nutrition knowledge will be assessed through the adapted Slater Nutrition Knowledge Survey.
These questions apply knowledge by asking participants to use their knowledge to make decisions rather than repeating the taught nutrition recommendations.
|
baseline, 12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lauren Ciszak, MD, Boston Medical Center, Department of Family Medicine
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-42380
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
HighTide Biopharma Pty LtdRecruitingT2DM (Type 2 Diabetes Mellitus)China
-
AstraZenecaNot yet recruiting
-
Daewoong Pharmaceutical Co. LTD.Not yet recruitingT2DM (Type 2 Diabetes Mellitus)
-
Zhongda HospitalRecruitingType 2 Diabetes Mellitus (T2DM)China
Clinical Trials on Mobile application
-
Mississippi State UniversityRecruiting
-
George Washington UniversityMedia RezRecruiting
-
University of ReginaCompletedStress | Dementia | Caregiver BurdenCanada
-
University Hospitals Cleveland Medical CenterCompleted
-
Ankara Yildirim Beyazıt UniversityNot yet recruiting
-
University of CadizRecruiting
-
Instituto de investigación e innovación biomédica...Completed
-
Oslo University HospitalDiakonhjemmet Hospital; South-Eastern Norway Regional Health AuthorityCompletedRheumatic Diseases | Chronic DiseaseNorway
-
University of VermontCompletedOsteoarthritis of Knee | Osteoarthritis Of HipUnited States
-
University of MichiganCompletedHeart FailureUnited States